Hemispherx Biopharma buy melinda
Start price
18.08.10
/
50%
€231.79
Target price
18.02.11
€462.00
Performance (%)
-20.05%
End price
18.02.11
€185.33
Summary
This prediction ended on 18.02.11 with a price of €185.33. The prediction for Hemispherx Biopharma disappointed with a performance of -20.05%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hemispherx Biopharma | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by melinda for this prediction
In the thread Hemispherx Biopharma diskutieren
Biopharma-
hemispherix Biopharma verkündete seine Schlacht gewonnen sechs Jahren südafrikanischen Investoren, dass sie gewonnen haben
(Laufzeit überschritten)
Stopped prediction by melinda for Hemispherx Biopharma
Hemispherx Biopharma
Start price
Target price
Perf. (%)
€20.02
18.05.17
18.05.17
€26.40
26.05.17
26.05.17
5.27%
26.05.17
26.05.17
